Page last updated: 2024-09-05

organophosphonates and Bone Diseases, Metabolic

organophosphonates has been researched along with Bone Diseases, Metabolic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, SH; Cho, YK; Choi, W; Han, KH; Hong, GY; Jang, JY; Jin, SY; Jung, YK; Kim, DJ; Kim, HS; Kim, JH; Kim, KH; Kim, MY; Kim, W; Kim, YJ; Kweon, YO; Lee, BS; Lee, JW; Lee, KS; Lee, WS; Lim, YS; Park, NH; Park, SJ; Sohn, JH; Um, SH; Yang, JM; Yim, HJ; Yoon, SK1
Assoumou, L; Bentata, M; Costagliola, D; Katlama, C; Kolta, S; Roux, C; Rozenberg, S; Simon, A; Viard, JP1
Eguchi, H; Hiromatsu, Y; Kuwahara, R; Tani, J; Tsuruta, M1
Becker, CB; Hamnvik, OP; Levy, BD; Loscalzo, J1
Dong, GF; Li, L; Xie, YS; Zhang, X1

Reviews

1 review(s) available for organophosphonates and Bone Diseases, Metabolic

ArticleYear
Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:3

    Topics: Adenine; Bone Diseases, Metabolic; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Osteomalacia

2014

Trials

1 trial(s) available for organophosphonates and Bone Diseases, Metabolic

ArticleYear
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9

    Topics: Absorptiometry, Photon; Adult; Alanine Transaminase; Antiviral Agents; Bone Density; Bone Diseases, Metabolic; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Glomerular Filtration Rate; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hip; Humans; Lumbar Vertebrae; Male; Maleates; Middle Aged; Organophosphonates; Osteoporosis; Renal Insufficiency; Sustained Virologic Response; Tenofovir; Treatment Outcome

2019

Other Studies

3 other study(ies) available for organophosphonates and Bone Diseases, Metabolic

ArticleYear
Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    AIDS (London, England), 2013, Sep-24, Volume: 27, Issue:15

    Topics: Absorptiometry, Photon; Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Bone Density; Bone Diseases, Metabolic; Hip; HIV Infections; HIV-1; Humans; Lumbar Vertebrae; Male; Middle Aged; Organophosphonates; Risk Factors; Tenofovir

2013
Clinical problem-solving. Wasting away.
    The New England journal of medicine, 2014, Mar-06, Volume: 370, Issue:10

    Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Female; Hepatitis B; Humans; Hypophosphatemia; Liver Function Tests; Organophosphonates; Pelvic Bones; Phosphates; Radiography; Reverse Transcriptase Inhibitors; Tenofovir

2014
[Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2011, Volume: 31, Issue:11

    Topics: Adenine; Antiviral Agents; Bone Diseases, Metabolic; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Hypophosphatemia; Male; Muscle Weakness; Organophosphonates; Osteomalacia; Young Adult

2011